Ledger.Open graph →
SEC Form D · filed July 30, 2020

Verona Pharma plc

Offering
$200.2M
Sold
$200.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
London, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Ken W. Cunningham · London, United KingdomDirectorDavid Zaccardelli · London, United KingdomExec · DirectorVikas W. Sinha · London, United KingdomDirectorMahendra W. Shah · London, United KingdomDirectorAndrew W. Sinclair · London, United KingdomDirectorRishi W. Gupta · London, United KingdomDirectorDavid W. Ebsworth · London, United KingdomDirectorMark W. Hahn · London, United KingdomExecKathleen W. Rickard · London, United KingdomExecAnders W. Ullman · London, United KingdomDirectorClaire W. Poll · London, United KingdomExecMartin W. Edwards · London, United KingdomDirectorAndrew W. Sinclair · London, United KingdomDirectorMahendra W. Shah · London, United KingdomDirectorRishi W. Gupta · London, United KingdomDirectorDavid W. Ebsworth · London, United KingdomDirectorMark W. Hahn · London, United KingdomExecKathleen W. Rickard · London, United KingdomExecAnders W. Ullman · London, United KingdomDirectorClaire W. Poll · London, United KingdomExecMartin W. Edwards · London, United KingdomDirectorKen W. Cunningham · London, United KingdomDirectorDavid Zaccardelli · London, United KingdomExec · DirectorVikas W. Sinha · London, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗